Guggenheim Reiterates Buy Rating for Cigna Group with $318 PT.

Guggenheim reiterates its Buy rating for Cigna Group (CI) with a $318 price target. The analyst has maintained its rating and price target since February 2023, showcasing confidence in the company's valuation and performance expectations. Historical ratings demonstrate consistent analyst engagement with rating adjustments over recent months. Cigna Group primarily provides pharmacy benefit management and health insurance services, with a strong position in the US market and a recent multiyear deal with Centene. Analysts forecast an average target price of $327.37 with an upside of 19.14% from the current price of $274.78.